Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-03-13)Premium Content

Peregrine Pharmaceuticals Inc (PPHM)

2015-03-31@12:45:33 ET
Peregrine Pharmaceuticals Announces Promising Bavituximab Phase I Data Published in the Peer-Reviewed Journal Cancer Medicine in Advanced Metastatic Breast Cancer (PMZ)

2015-03-12@16:28:39 ET
10-Q: PEREGRINE PHARMACEUTICALS INC (EDG)

2015-03-12@16:00:08 ET
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results and Recent Developments (PMZ)

2015-03-12@08:55:00 ET
Scanning Biotech Equities -- Agenus, Amicus Therapeutics, Peregrine Pharma, Vanda Pharma, and Acorda Therapeutics (PRN)

2015-03-10@16:00:07 ET
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock (PMZ)

2015-03-06@21:26:26 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2015-03-05@21:30:05 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2015-03-05@16:00:08 ET
Peregrine Pharmaceuticals to Report Third Quarter Fiscal 2015 Financial Results After Market on March 12, 2015 (PMZ)

2015-03-03@13:39:04 ET
Stock to Watch: Peregrine Pharmaceuticals Up 5.7% (PPHM) (PSM)

2015-03-03@13:04:45 ET
Peregrine Pharmaceuticals Up 5.7%, Shares Break Through Resistance (PPHM) (F77)

2015-03-02@16:00:45 ET
Peregrine Pharmaceuticals to Present at the 27th Annual ROTH Conference (PMZ)

2015-02-27@13:04:50 ET
Stock to Watch: Peregrine Pharmaceuticals Up 9.1% (PPHM) (F77)

2015-02-27@11:34:02 ET
Peregrine Pharmaceuticals Up 9.4%, Shares Break Through Resistance (PPHM) (PSM)

2015-02-09@08:31:14 ET
Newly Presented Data Shows That Peregrine Pharmaceuticals' PS-Targeting Antibodies Significantly Enhance Anti-Tumor Activity of Immune Checkpoint Inhibitors PD-1 and CTLA-4 in Models of Breast Cancer and Melanoma (INW)

2015-02-07@21:13:56 ET
Peregrine Pharmaceuticals CorporationCorporate Event Announcement Notice (WSH)

2015-01-28@08:40:00 ET
Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma (PRN)

2015-01-16@09:30:35 ET
Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in Combination With Sorafenib Presented at ASCO Gastrointestinal Cancers Symposium (INW)

2015-01-08@13:06:19 ET
Stock to Watch: Peregrine Pharmaceuticals Up 7.9% (PPHM) (F77)

2015-01-08@11:35:54 ET
Stock to Watch: Peregrine Pharmaceuticals Up 6.4% (PPHM) (PSM)